Clinical trials
Active, not recruiting Endocrine System Diseases trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
16 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2016 | 1 |
| 2017 | 1 |
| 2019 | 2 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 3 |
| 2024 | 4 |
| 2025 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 16 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eli Lilly and Company | 5 |
| Alexion Pharmaceuticals, Inc. | 1 |
| Anne-Sophie Brazeau | 1 |
| Aphaia Pharma US LLC | 1 |
| Felix Beuschlein | 1 |
| Gaia AG | 1 |
| M.D. Anderson Cancer Center | 1 |
| Pfizer | 1 |
| The First Affiliated Hospital of Zhengzhou University | 1 |
| University of Manitoba | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Endocrine System Diseases | 16 |
| Glucose Metabolism Disorders | 8 |
| Metabolic Diseases | 8 |
| Diabetes Mellitus, Type 2 | 7 |
| Diabetes Mellitus | 5 |
| Obesity | 5 |
| Lung Diseases | 3 |
| Neoplasms by Site | 3 |
| Body Weight | 2 |
| Breast Neoplasms | 2 |
Trials
Showing 76 to 16 of 16. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.